Entering text into the input field will update the search result below

Wall Street Favorite Healthcare Equities For July Topped By CVS Health

Aug. 01, 2018 2:27 AM ETAB, ABBV, ABT, AGN, AZN, CAH, CVS, FMS, GILD, GSK, MCK, NVS, PDCO, PFE, PMD, SNY1 Comment


  • Big pharma drug makers and biotech issues continue to top the healthcare sector by yield and broker targets. WallStars are distinguished by positive broker target price upsides.
  • The Healthcare sector is composed of ten component industries. The 47 firms selected by broker target price upsides for this writing represented nine of those industries.
  • Those 47 Health WallStars ranged in yield from 0.52% to 4.88%. Top ten, GILD, PMD, PFE, NVS, AZN, CAH, ABBV, PDCO, SNY and GSK, averaged 3.86%.
  • Four of ten top yield Healthcare stocks made the top ten of thirty for gains. The ten top gainers averaged 18.6% in estimated 1yr. price gains.
  • $5k invested in the lowest-priced five July top-yield Healthcare stocks showed 49.19% less net gain than that derived from all ten. Big Healthcare stocks ruled the sector.
  • Members of my private investing community, The Dividend Dog Catcher, can follow this idea, as well as my other top picks with access to my model portfolio. Start your free trial today >>

Actionable Conclusions (1-10): Analysts Projected 12.6% To 28.5% Net Gains For Top Ten Healthcare WallStars By July 2019

Four of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on broker 1-year target prices. (They are tinted gray in the chart above). Thus, this yield-based forecast for Healthcare WallStars as graded by Wall St. proved 40% accurate.

Projections based on estimated dividend amounts from $1000 invested in the ten highest yielding stocks and the aggregate one-year analyst mean target prices for those stocks as reported by YCharts produced the 2019 data. Note: one-year target prices from one analyst were not applied (n/a). Ten probable profit-generating trades to 2019 were:

CVS Health (CVS) was projected to net $285.06 based on annual dividend plus a mean target price estimate from twenty-three analysts, less broker fees. The Beta number showed this estimate subject to volatility equal to the market as a whole.

McKesson (MCK) was projected to net $229.88, based on dividends, plus a mean target price estimate from eighteen analysts, less broker fees. The Beta number showed this estimate subject to volatility 29% more than the market as a whole.

AbbVie (ABBV) was projected to net $209.52, based on dividends plus a mean target price estimate from twenty-three analysts, less broker fees. The Beta number showed this estimate subject to volatility 61% more than the market as a whole.

AmerisourceBergen (AB) netted $200.84 based on median target price estimates from eighteen analysts plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 4% more than the market as a whole.

Cardinal Health (CAH) was projected to net $180.26, based on a median target price estimate from eighteen analysts plus annual dividend, less broker fees. The Beta number showed this estimate

Three or more of these top Healthcare WallStars by yield qualify as valuable catches! Find them among the now 52 Dogs of the Week I found on The Dividend Dog Catcher premium is accumulating returns. Also, a Dogs of the Week III (Safari to Sweet Success) portfolio launched September 8 now shows 47 new selections. Click here to subscribe or get more information.

Make investing gains again. Catch your underdog on Facebook!

At 8:45 AM nearly every NYSE trading day on Facebook/ Dividend Dog Catcher Fredrik Arnold does a quick live video summary of one of four or five stocks contending for a single weekly slot in his Safari To Sweet Success portfolio.

Go to Facebook/Dividend Dog Catcher at 8:45 AM most trading days and watch, like, comment and share that live video. Of course you're welcome to view all the replays, too, anytime.

Yet always remember: Root for the Underdog

This article was written by

Fredrik Arnold profile picture
Simple, straightforward 7-step analysis that finds lucrative income stocks.
Fredrik Arnold is my pen name. In 2012 I retired from doing quality service analysis in Boston and moved to North Carolina in 2013, thence to Central Oregon in 2018. My fascination with capital preservation, long-term investments, and trading systems keeps me blogging for Seeking Alpha. My articles focus on dividend yields, analyst median 1 yr targets, free cash flow yields, and one-year total returns as stock trading indicators. These are essential tools for catching the most valuable dividend dogs. My dividend dogcatcher premium site in the Seeking Alpha Marketplace shows annual real-time trading results since 2015.

Analyst’s Disclosure: I am/we are long PFE, MFCSF. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.